Evidence supporting pathological effects of mutations due to anomalous non-canonical aaRS functions comes from mouse model for CMT where a mutant GRS retains wild-type aminoacylation activity [71]. The gene discussed is BCL2A1; the disease is Charcot-Marie-Tooth disease.